“…Similarly, very little is known about the repercussions of this disease on mortality rates. [4][5][6][7][8] Many structural barriers are difficult to overcome, such as lack of implementation of screening programs and lack of validated diagnostic tests, particularly in rural areas. There is no entity that monitors these processes, and positive cases may not receive confirmation or access to treatment.…”